COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 1239: Articles 12381-12390  | Next

Population birth outcomes in 2020 and experiences of expectant mothers during the COVID-19 pandemic: a Born in Wales mixed methods study using routine data
Jones, H., Seaborne, M., Cowley, L., Odd, D. E., Paranjothy, S., Akbari, A., Brophy, S.
10.1101/2021.08.23.21262209 — Posted: 2021-08-23
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia
Barchuk, A., Cherkashin, M., Bulina, A., Berezina, N., Rakova, T., Kuplevatskaya, D., Stanevich, O., Skougarevskiy, D., Okhotin, A.
10.1101/2021.08.18.21262065 — Posted: 2021-08-23
Improving the reproduction number calculation by treating for daily variations of SARS-CoV-2 cases
Drewes, H., Flaeschner, G., Moeller, P.
10.1101/2021.08.15.21262071 — Posted: 2021-08-23
Comparison of the inhomogeneous SEPIR model and data from the COVID-19 outbreak in South Carolina
Granek, R., Tsori, Y.
10.1101/2021.08.15.21262074 — Posted: 2021-08-23
Gene-environment interaction analysis incorporating sex, cardiometabolic diseases, and multiple deprivation index reveals novel genetic associations with COVID-19 severity
Westerman, K. E., Lin, J., Sevilla-Gonzalez, M., Tadess, B., Manning, A. K., Marchek, C. J.
10.1101/2021.08.13.21261910 — Posted: 2021-08-23
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England
Whiteley, W., Ip, S., Cooper, J. A., Bolton, T., Keene, S., Walker, V., Denholm, R., Akbari, A., Omigie, E., Hollings, S., Di Angelantonio, E., Denaxas, S., Wood, A., Sterne, J., Sudlow, C., CVD-COVID-UK consortium
10.1101/2021.08.18.21262222 — Posted: 2021-08-23
Multiplex Target-Redundant RT-LAMP for Robust Detection of SARS-CoV-2 Using Fluorescent Universal Displacement Probes
Kline, E. C., Panpradist, N., Hull, I. T., Wang, Q., Oreskovic, A. K., Han, P. D., Starita, L. M., Lutz, B. R.
10.1101/2021.08.13.21261995 — Posted: 2021-08-23
Nanopore Metagenomic Sequencing for Detection and Characterization of SARS-CoV-2 in Clinical Samples
Gauthier, N. P. G., Nelson, C., Bonsall, M. B., Locher, K., Charles, M., MacDonald, C., Krajden, M., Chorlton, S. D., Manges, A. R.
10.1101/2021.08.13.21261922 — Posted: 2021-08-23
Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation
Habel, J., Chua, B., Kedzierski, L., Selva, K., Damelang, T., Haycroft, E., Nguyen, T. H. O., Koay, H.-F., Nicholson, S., McQuilten, H., Jia, X., Allen, L., Hensen, L., Zhang, W., van de Sandt, C., Neil, J., Amanat, F., Krammer, F., Wragg, K., Juno, J. A., Wheatley, A. K., Tan, H.-X., Pell, G., Audsley, J., Thevarajan, I., Denholm, J., Subbarao, K., Godfrey, D., Cheng, A., Tong, S., Bond, K., Williamson, D., James, F., Holmes, N., Smibert, O., Trubiano, J. A., Gordon, C., Chung, A. A., Whitehead, C., Kent, S., Lappas, M., Rowntree, L., Kedzierska, K.
10.1101/2021.08.21.21262399 — Posted: 2021-08-23
Anti-PF4 levels of patients with VITT do not reduce 4 months following AZD1222 vaccination
Nicolson, P. L., Montague, S. J., Smith, C. W., Lodwick, C. S., Stoneley, C., Roberts, M., Watson, S. P., Lowe, G. C., Lester, W. A.
10.1101/2021.08.17.21262138 — Posted: 2021-08-23 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).